Transcranial Static Field Stimulation (tSMS) and Transcranial Direct Current Stimulation (tDCS) for the Treatment of Neurological Symptoms
Summary
The presence of damage to the central and/or peripheral nervous system resulting from various pathologies, such as Multiple Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), Parkinson's disease (PD), Alzheimer's disease (AD), dementia, traumatic brain injury (TBI), stroke, or other neurological syndromes, is commonly a cause of both physical and mental disability.
Why it matters
This research addresses an important unmet clinical need in treating Neurological Diseases or Conditions through innovative neurotechnology approaches. The findings from this study could meaningfully advance patient care by providing rigorous clinical evidence for new therapeutic interventions. Successful results may ultimately lead to improved treatment guidelines, expanded access to care, and significantly better long-term outcomes for affected patients worldwide.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial